Now With Our Own Lab - Reach Out To Learn More
About Us
Calley Hirsch, - VP of Preclinical Development at Morphocell Technologies
- 19+ years of stem cell and developmental biology experience
- Expert in iPSC derivation & genome engineering
- Specialized in preclinical process & analytical development of iPSC-derived and primary cell therapies
- CMC strategy leader for new product concepts
Panos Chrysanthopoulos, PhD - CDO at Morphocell Technologies
- 19+ years international experience in systems biology-based process & analytical development
- Preclinical & clinical C> process development & characterization (iPSC-derived & primary cells)
- Expert in DoE based process and analytical development
- QbD based product development & CMC strategy expert
Jessica Schwaber, Ph.D. - Snr. Director of Preclinical Development at Morphocell Technologies
- 15+ years experience in stem and mammalian cell biology/immunology & analytical development .
- Expert in C> clinical manufacturing and device development.
- Deep expertise in flow cytometry based cell characterization.
- Proven leader in product development, technology transfer, and cross-functional team management.
- Expert in preclinical development and CRO/CDMO management.
Javier Hernandez, PhD - Partner
- 10+ years of combined academic and industry research experience in stem cell biology, including extensive work with 2D & 3D differentiated derivative models.
- Led the development and commercialization of technology platforms spanning iPSCs, genome engineering, and molecular diagnostics.
- Skilled in Lean Six Sigma principles and DoE implementation.
- Expert in managing programs, teams, and mentoring graduate students.